Related references
Note: Only part of the references are listed.A Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET Imaging
Julien Dumurgier et al.
NEUROLOGY (2022)
Alzheimer's cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans CSF AD biomarkers measured by Lumipulse in Koreans
Sohee Moon et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
Application of modern neuroimaging technology in the diagnosis and study of Alzheimer's disease
Hong-Mei Zeng et al.
NEURAL REGENERATION RESEARCH (2021)
Disentangling Heterogeneity in Alzheimer's Disease and Related Dementias Using Data-Driven Methods
Mohamad Habes et al.
BIOLOGICAL PSYCHIATRY (2020)
The implications of different approaches to define AT(N) in Alzheimer disease
Niklas Mattsson-Carlgren et al.
NEUROLOGY (2020)
ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project
Jarith L. Ebenau et al.
NEUROLOGY (2020)
The dynamics of biomarkers across the clinical spectrum of Alzheimer's disease
Christoforos Hadjichrysanthou et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Sensitivity, Specificity and Potential for Clinical Use
Cristina D'Abramo et al.
JOURNAL OF PERSONALIZED MEDICINE (2020)
Challenges in Alzheimer's Disease Diagnostic Work-Up: Amyloid Biomarker Incongruences
Gemma Lombardi et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Impact of CSF storage volume on the analysis of Alzheimer's disease biomarkers on an automated platform
Constance Delaby et al.
CLINICA CHIMICA ACTA (2019)
Advantages and disadvantages of the use of the CSF Amyloid (A) 42/40 ratio in the diagnosis of Alzheimer's Disease
Oskar Hansson et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Analytical and clinical performances of the automated Lumipulse cerebrospinal fluid Aβ42 and T-Tau assays for Alzheimer's disease diagnosis
Jean-Louis Bayart et al.
JOURNAL OF NEUROLOGY (2019)
Applying the ATN scheme in a memory clinic population The ABIDE project
Daniele Altomare et al.
NEUROLOGY (2019)
Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer's disease
Maria Joao Leitao et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Predicting clinical decline and conversion to Alzheimer's disease or dementia using novel Elecsys Aβ(1-42), pTau and tTau CSF immunoassays
Kaj Blennow et al.
SCIENTIFIC REPORTS (2019)
Machine Learning in Medicine
Ben Van Calster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
Oskar Hansson et al.
ALZHEIMERS & DEMENTIA (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Big Data and Machine Learning in Health Care
Andrew L. Beam et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Alzheimer's disease and other dementias: update on research
Lon Schneider
LANCET NEUROLOGY (2017)
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment
Sanna-Kaisa Herukka et al.
ALZHEIMERS & DEMENTIA (2017)
The Gothenburg MCI study: Design and distribution of Alzheimer's disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up
Anders Wallin et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2016)
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
Clifford R. Jack et al.
NEUROLOGY (2016)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Machine learning for medical diagnosis: history, state of the art and perspective
I Kononenko
ARTIFICIAL INTELLIGENCE IN MEDICINE (2001)
Share Paper
